Fact CheckerSign in

NCT07200856Not yet recruiting

Nocturnal Blood Pressure Dipping and Ventricular Repolarization in Hypertension

Impact of Nocturnal Blood Pressure Dipping on Ventricular Repolarization in Hypertensive Patients

Source: ClinicalTrials.gov · Last updated 1 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The primary aim is to determine whether non-dipping status is associated with adverse repolarization markers and impaired myocardial mechanics compared to dipper hypertensive patients. Secondary analyses will compare these findings among resistant vs. non-resistant and controlled vs. uncontrolled hypertensive groups. This study may provide new insights into the prognostic significance of blood pressure dipping patterns in hypertensive patients.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
140 (estimated)
First submitted
23 Sept 2025
Start date
Oct 2025
Primary completion date
Oct 2026
Lead sponsor
Assiut University
NCT number
NCT07200856

What you commit to

  • Study type: Observational
  • Planned participants: 140
  • From Oct 2025 to the primary completion date, Oct 2026
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior coronary revascularization (PCI or CABG)

Other illness

  • End-stage renal disease or liver failure

Lab values

  • Use of QT-prolonging medications

Other

  • Body mass index (BMI) \> 34.9 kg/m²
  • Atrial fibrillation or atrial flutter
  • Bundle branch block or presence of pacemaker
  • Significant electrolyte imbalance

Who the study is looking for

  • Adults ≥18 years old
  • Diagnosed with essential hypertension
  • Completed 24-hour ambulatory blood pressure monitoring (ABPM)
  • Availability of good-quality 12-lead ECG
  • Availability of good-quality transthoracic echocardiography

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.